                         SEQUENCE LISTING

<110>  NANOVIS, INC.
       HEDRICK, Matthew
       BALASUNDARAM, Ganesan
 
<120>  BIOMIMETIC PEPTIDES FOR BONE AUGMENTATION

<130>  2891.025AWO

<150>  US 61/358,859
<151>  2010-06-25

<160>  15    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Syntentic peptide

<400>  1

Lys Arg Ser Arg 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Lys Ser Arg Arg 
1               


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Lys Arg Ser Arg Gly Gly Gly Gly Tyr 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Lys Ser Arg Arg Gly Gly Gly Gly Tyr 
1               5                   


<210>  5
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Lys Pro Ser Ser Ala Pro Thr Gln Leu Asn 
1               5                   10  


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Ala Ile Ser Val Leu Tyr Phe Asp Asp Ser 
1               5                   10  


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Ser Asn Val Ile Leu Lys Lys Tyr Arg Asn 
1               5                   10  


<210>  8
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  8

Lys Arg Ser Arg Ser Asn Val Ile Leu Lys Lys Tyr Arg Asn 
1               5                   10                  


<210>  9
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  9

Lys Arg Ser Arg Gly Gly Gly Gly Lys Pro Ser Ser Ala Pro Thr Gln 
1               5                   10                  15      


Leu Asn 
        


<210>  10
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  10

Lys Arg Ser Arg Gly Gly Gly Gly Ala Ile Ser Val Leu Tyr Phe Asp 
1               5                   10                  15      


Asp Ser 
        


<210>  11
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  11

Lys Arg Ser Arg Gly Gly Gly Gly Ser Asn Val Ile Leu Lys Lys Tyr 
1               5                   10                  15      


Arg Asn 
        


<210>  12
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  12

Lys Arg Ser Arg Gly Gly Gly Gly Lys Pro Ser Ser Ala Pro Thr Gln 
1               5                   10                  15      


Leu Asn Ala Ile Ser Val Leu Tyr Phe Asp Asp Ser 
            20                  25              


<210>  13
<211>  28
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  13

Lys Arg Ser Arg Gly Gly Gly Gly Ala Ile Ser Val Leu Tyr Phe Asp 
1               5                   10                  15      


Asp Ser Ser Asn Val Ile Leu Lys Lys Tyr Arg Asn 
            20                  25              


<210>  14
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  14

Lys Arg Ser Arg Gly Gly Gly Gly Lys Pro Ser Ser Ala Pro Thr Gln 
1               5                   10                  15      


Leu Asn Ala Ile Ser Val Leu Tyr Phe Asp Asp Ser Ser Asn Val Ile 
            20                  25                  30          


Leu Lys Lys Tyr Arg Asn 
        35              


<210>  15
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  15

Arg Gly Asp Ser 
1               


